Efficacy and safety of once daily insulin glargine therapy for people with type 2 diabetes inadequately controlled with DPP4 inhibitor and several OADs
Not Applicable
Recruiting
- Conditions
- Type 2 Diabetes
- Registration Number
- JPRN-UMIN000007375
- Lead Sponsor
- Tokyo Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Exclusion Criteria: 1) Patients except type 2 diabetic patients. 2) Patients taking Probucol, vitamin E and/or vitamin C. 3) Alcoholic,or heavy drinker. 4) Patients operated malignant and gastro extraction. 5) Patients with serious complications of DM. Nephropathy:*. Retinopathy:** 6) Drug anaphylaxis patient. 7) Pregnant or patients who plan to carry, or currently breast-feeding woman. 8) Patients who were judged inappropriate to participate in this study by the doctor of study director or cooperative
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method